Stericycle (SRCL) Stock Forecast, Price Target & Predictions
SRCL Stock Forecast
Stericycle stock forecast is as follows: an average price target of $56.33 (represents a -8.72% downside from SRCL’s last price of $61.71) and a rating consensus of 'Hold', based on 2 wall street analysts offering a 1-year stock forecast.
SRCL Price Target
The average price target for Stericycle (SRCL) is $56.33 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $62.00 to $45.00. This represents a potential -8.72% downside from SRCL's last price of $61.71.
SRCL Analyst Ratings
According to 2 Wall Street analysts, Stericycle's rating consensus is 'Hold'. The analyst rating breakdown for SRCL stock is 0 'Strong Buy' (0.00%), 0 'Buy' (0.00%), 2 'Hold' (100.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Stericycle Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jun 20, 2024 | Michael Hoffman | Stifel Nicolaus | $62.00 | $58.44 | 6.09% | 0.47% |
| Jun 03, 2024 | Sector Perform | RBC Capital | $62.00 | $59.05 | 5.00% | 0.47% |
| Jun 03, 2024 | Michael Hoffman | Stifel Nicolaus | $75.00 | $51.54 | 45.52% | 21.54% |
| Apr 18, 2023 | Tobey Sommer | Truist Financial | $45.00 | $41.80 | 7.66% | -27.08% |
The latest Stericycle stock forecast, released on Jun 20, 2024 by Michael Hoffman from Stifel Nicolaus, set a price target of $62.00, which represents a 6.09% increase from the stock price at the time of the forecast ($58.44), and a 0.47% increase from SRCL last price ($61.71).
Stericycle Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 3 |
| Avg Price Target | - | $62.00 | $66.33 |
| Last Closing Price | $61.71 | $61.71 | $61.71 |
| Upside/Downside | -100.00% | 0.47% | 7.49% |
In the current month, the average price target of Stericycle stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Stericycle's last price of $61.71. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jun 04, 2024 | Truist Financial | Sector Perform | Sector Perform | Hold |
| Jun 03, 2024 | RBC Capital | Outperform | Sector Perform | Downgrade |
| Feb 29, 2024 | RBC Capital | Outperform | Outperform | Hold |
| Aug 08, 2022 | RBC Capital | Outperform | Outperform | Hold |
Stericycle's last stock rating was published by Truist Financial on Jun 04, 2024. The company gave SRCL a "Sector Perform" rating, the same as its previous rate.
Stericycle Financial Forecast
Stericycle Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $652.00M | $653.50M | $669.50M | $684.30M | $670.40M | $690.30M | - | $664.20M | $657.30M | $648.90M | $672.70M | $668.00M | $655.90M | $636.40M | $598.20M | $785.00M | $799.90M | $833.10M |
| Avg Forecast | $711.30M | $714.30M | $702.90M | $705.20M | $704.00M | $703.00M | $694.00M | $685.00M | $674.73M | $672.92M | $667.45M | $676.42M | $657.99M | $679.03M | $683.48M | $670.38M | $697.18M | $675.21M | $674.64M | $671.00M | $659.84M | $671.71M | $669.15M | $648.52M | $651.10M | $642.84M | $595.59M | $795.22M | $807.68M | $842.21M |
| High Forecast | $717.99M | $721.02M | $709.52M | $711.84M | $710.63M | $709.62M | $700.53M | $691.45M | $681.08M | $683.08M | $673.73M | $682.78M | $666.52M | $685.42M | $689.91M | $676.69M | $703.75M | $681.56M | $674.64M | $680.01M | $668.69M | $680.73M | $678.13M | $657.23M | $659.84M | $651.47M | $603.59M | $805.90M | $818.52M | $853.51M |
| Low Forecast | $704.61M | $707.58M | $696.28M | $698.56M | $697.37M | $696.38M | $687.47M | $678.55M | $668.38M | $665.75M | $661.17M | $670.05M | $654.01M | $672.64M | $677.04M | $664.07M | $690.62M | $668.85M | $674.64M | $657.90M | $646.95M | $658.59M | $656.08M | $635.86M | $638.38M | $630.29M | $583.96M | $779.70M | $791.91M | $825.77M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 2 | 1 | 2 | 2 | 2 | 4 | 4 | 7 | 4 | 4 | 3 | 5 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.99% | 0.96% | 0.98% | 1.02% | 0.96% | 1.02% | - | 0.99% | 1.00% | 0.97% | 1.01% | 1.03% | 1.01% | 0.99% | 1.00% | 0.99% | 0.99% | 0.99% |
Stericycle's average Quarter revenue forecast for Mar 24 based on 3 analysts is $676.42M, with a low forecast of $670.05M, and a high forecast of $682.78M. SRCL's average Quarter revenue forecast represents a 3.74% increase compared to the company's last Quarter revenue of $652.00M (Dec 23).
Stericycle EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 2 | 1 | 2 | 2 | 2 | 4 | 4 | 7 | 4 | 4 | 3 | 5 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $37.10M | $24.20M | $-24.00M | $100.00M | $43.40M | $111.60M | - | $64.80M | $64.10M | $6.50M | $111.30M | $113.60M | $147.20M | $700.00K | $83.70M | $26.40M | $-135.20M | $29.80M |
| Avg Forecast | $94.54M | $94.94M | $93.43M | $93.73M | $93.57M | $93.44M | $92.24M | $91.05M | $89.68M | $89.44M | $88.71M | $102.11M | $87.46M | $90.25M | $90.84M | $92.83M | $92.67M | $8.78M | $89.67M | $84.39M | $76.37M | $7.98M | $112.94M | $90.49M | $156.55M | $550.00K | $72.71M | $28.72M | $-131.34M | $24.54M |
| High Forecast | $95.43M | $95.83M | $94.30M | $94.61M | $94.45M | $94.32M | $93.11M | $91.90M | $90.53M | $90.79M | $89.55M | $122.54M | $88.59M | $91.10M | $91.70M | $111.40M | $93.54M | $10.54M | $89.67M | $101.27M | $91.65M | $9.58M | $135.52M | $108.59M | $187.86M | $660.00K | $87.25M | $34.46M | $-105.07M | $29.45M |
| Low Forecast | $93.65M | $94.05M | $92.55M | $92.85M | $92.69M | $92.56M | $91.37M | $90.19M | $88.84M | $88.49M | $87.88M | $81.69M | $86.93M | $89.40M | $89.99M | $74.26M | $91.79M | $7.02M | $89.67M | $67.51M | $61.10M | $6.39M | $90.35M | $72.40M | $125.24M | $440.00K | $58.17M | $22.97M | $-157.60M | $19.63M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.42% | 0.27% | -0.26% | 1.08% | 0.47% | 12.71% | - | 0.77% | 0.84% | 0.81% | 0.99% | 1.26% | 0.94% | 1.27% | 1.15% | 0.92% | 1.03% | 1.21% |
3 analysts predict SRCL's average Quarter EBITDA for Mar 24 to be $102.11M, with a high of $122.54M and a low of $81.69M. This is 175.24% upper than Stericycle's previous annual EBITDA (Dec 23) of $37.10M.
Stericycle Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 2 | 1 | 2 | 2 | 2 | 4 | 4 | 7 | 4 | 4 | 3 | 5 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $14.90M | $11.70M | $-49.50M | $11.20M | $31.80M | $28.00M | - | $-14.10M | $-16.40M | $-66.00M | $29.30M | $26.10M | $48.50M | $-81.20M | $-4.50M | $-20.10M | $-219.30M | $-59.20M |
| Avg Forecast | $79.98M | $68.82M | $69.75M | $69.75M | $70.68M | $64.17M | $61.38M | $51.15M | $54.63M | $51.69M | $50.86M | $-22.41M | $43.44M | $42.16M | $45.41M | $-20.37M | $55.99M | $-89.16M | $44.48M | $-18.52M | $-20.49M | $-81.05M | $29.73M | $20.79M | $51.58M | $-63.80M | $-3.91M | $-21.86M | $-213.03M | $-48.75M |
| High Forecast | $80.96M | $69.66M | $70.60M | $70.60M | $71.54M | $64.95M | $62.13M | $51.78M | $55.30M | $52.58M | $51.48M | $-17.93M | $47.14M | $42.68M | $45.97M | $-16.30M | $56.67M | $-71.33M | $44.48M | $-14.82M | $-16.39M | $-64.84M | $35.68M | $24.95M | $61.90M | $-51.04M | $-3.13M | $-17.49M | $-170.43M | $-39.00M |
| Low Forecast | $79.00M | $67.98M | $68.90M | $68.90M | $69.82M | $63.39M | $60.63M | $50.52M | $53.97M | $49.91M | $50.24M | $-26.89M | $41.60M | $41.64M | $44.86M | $-24.45M | $55.30M | $-106.99M | $44.48M | $-22.23M | $-24.59M | $-97.26M | $23.78M | $16.63M | $41.26M | $-76.56M | $-4.69M | $-26.24M | $-255.64M | $-58.50M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.34% | 0.28% | -1.09% | -0.55% | 0.57% | -0.31% | - | 0.76% | 0.80% | 0.81% | 0.99% | 1.26% | 0.94% | 1.27% | 1.15% | 0.92% | 1.03% | 1.21% |
Stericycle's average Quarter net income forecast for Mar 24 is $-22.41M, with a range of $-26.89M to $-17.93M. SRCL's average Quarter net income forecast represents a -250.41% decrease compared to the company's last Quarter net income of $14.90M (Dec 23).
Stericycle SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 2 | 1 | 2 | 2 | 2 | 4 | 4 | 7 | 4 | 4 | 3 | 5 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $219.70M | $217.30M | $220.90M | $216.00M | $210.90M | $215.60M | - | $238.60M | $251.40M | $279.40M | $213.50M | $202.30M | $218.90M | $219.00M | $201.00M | $258.70M | $250.00M | $247.40M |
| Avg Forecast | $228.47M | $229.43M | $225.77M | $226.51M | $226.13M | $225.81M | $222.91M | $220.02M | $216.72M | $216.14M | $214.39M | $376.57M | $211.35M | $218.11M | $219.53M | $342.34M | $223.94M | $377.44M | $216.70M | $311.22M | $299.54M | $343.12M | $216.64M | $161.15M | $232.80M | $172.07M | $174.61M | $281.39M | $242.86M | $203.74M |
| High Forecast | $230.62M | $231.59M | $227.90M | $228.64M | $228.25M | $227.93M | $225.01M | $222.09M | $218.76M | $219.41M | $216.40M | $451.89M | $214.09M | $220.16M | $221.60M | $410.81M | $226.04M | $452.92M | $216.70M | $373.46M | $359.45M | $411.75M | $259.97M | $193.39M | $279.36M | $206.49M | $209.53M | $337.67M | $291.43M | $244.49M |
| Low Forecast | $226.32M | $227.28M | $223.65M | $224.38M | $224.00M | $223.68M | $220.82M | $217.95M | $214.68M | $213.84M | $212.37M | $301.26M | $210.07M | $216.05M | $217.47M | $273.87M | $221.83M | $301.95M | $216.70M | $248.97M | $239.63M | $274.50M | $173.31M | $128.92M | $186.24M | $137.66M | $139.68M | $225.11M | $194.29M | $162.99M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.04% | 1.00% | 1.01% | 0.63% | 0.94% | 0.57% | - | 0.77% | 0.84% | 0.81% | 0.99% | 1.26% | 0.94% | 1.27% | 1.15% | 0.92% | 1.03% | 1.21% |
Stericycle's average Quarter SG&A projection for Mar 24 is $376.57M, based on 3 Wall Street analysts, with a range of $301.26M to $451.89M. The forecast indicates a 71.40% rise compared to SRCL last annual SG&A of $219.70M (Dec 23).
Stericycle EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 2 | 1 | 2 | 2 | 2 | 4 | 4 | 7 | 4 | 4 | 3 | 5 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $0.16 | $0.13 | $-0.54 | $0.12 | $0.35 | $0.30 | - | $-0.15 | $-0.18 | $-0.72 | $0.32 | $0.29 | $0.53 | $-0.89 | $-0.05 | $-0.22 | $-2.41 | $-0.65 |
| Avg Forecast | $0.86 | $0.74 | $0.75 | $0.75 | $0.76 | $0.69 | $0.66 | $0.55 | $0.59 | $0.56 | $0.55 | $0.56 | $0.47 | $0.45 | $0.49 | $0.44 | $0.60 | $0.58 | $0.48 | $0.46 | $0.47 | $0.60 | $0.69 | $0.59 | $0.63 | $0.56 | $0.28 | $0.58 | $0.69 | $0.68 |
| High Forecast | $0.87 | $0.75 | $0.76 | $0.76 | $0.77 | $0.70 | $0.67 | $0.56 | $0.59 | $0.57 | $0.55 | $0.56 | $0.51 | $0.46 | $0.49 | $0.44 | $0.61 | $0.59 | $0.48 | $0.47 | $0.47 | $0.61 | $0.70 | $0.60 | $0.64 | $0.57 | $0.29 | $0.59 | $0.71 | $0.69 |
| Low Forecast | $0.85 | $0.73 | $0.74 | $0.74 | $0.75 | $0.68 | $0.65 | $0.54 | $0.58 | $0.54 | $0.54 | $0.55 | $0.45 | $0.45 | $0.48 | $0.43 | $0.59 | $0.57 | $0.48 | $0.45 | $0.45 | $0.58 | $0.67 | $0.57 | $0.62 | $0.55 | $0.28 | $0.57 | $0.68 | $0.66 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.34% | 0.29% | -1.11% | 0.27% | 0.58% | 0.52% | - | -0.32% | -0.39% | -1.21% | 0.46% | 0.49% | 0.84% | -1.58% | -0.18% | -0.38% | -3.47% | -0.95% |
According to 3 Wall Street analysts, Stericycle's projected average Quarter EPS for Mar 24 is $0.56, with a low estimate of $0.55 and a high estimate of $0.56. This represents a 247.24% increase compared to SRCL previous annual EPS of $0.16 (Dec 23).
Stericycle Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| MEG | Montrose Environmental Group | $29.16 | $52.50 | 80.04% | Buy |
| GFL | GFL Environmental | $40.03 | $44.90 | 12.17% | Buy |
| CWST | Casella Waste Systems | $108.06 | $112.00 | 3.65% | Strong Buy |
| SRCL | Stericycle | $61.71 | $56.33 | -8.72% | Hold |
| WCN | Waste Connections | $185.68 | $165.13 | -11.07% | Buy |
| RSG | Republic Services | $205.79 | $180.50 | -12.29% | Buy |
| CLH | Clean Harbors | $243.97 | $197.13 | -19.20% | Buy |
SRCL Forecast FAQ
Is Stericycle a good buy?
No, according to 2 Wall Street analysts, Stericycle (SRCL) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 0 'Buy' recommendations, accounting for 0% of SRCL's total ratings.
What is SRCL's price target?
Stericycle (SRCL) average price target is $56.33 with a range of $45 to $62, implying a -8.72% from its last price of $61.71. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Stericycle stock go up soon?
According to Wall Street analysts' prediction for SRCL stock, the company can go down by -8.72% (from the last price of $61.71 to the average price target of $56.33), up by 0.47% based on the highest stock price target, and down by -27.08% based on the lowest stock price target.
Can Stericycle stock reach $90?
SRCL's average twelve months analyst stock price target of $56.33 does not support the claim that Stericycle can reach $90 in the near future.
What are Stericycle's analysts' financial forecasts?
Stericycle's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $2.79B (high $2.81B, low $2.76B), average EBITDA is $370.3M (high $373.78M, low $366.81M), average net income is $247.38M (high $250.41M, low $244.35M), average SG&A $894.87M (high $903.29M, low $886.45M), and average EPS is $2.66 (high $2.69, low $2.63). SRCL's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $2.83B (high $2.86B, low $2.81B), average EBITDA is $376.64M (high $380.18M, low $373.1M), average net income is $288.3M (high $291.83M, low $284.77M), average SG&A $910.19M (high $918.76M, low $901.62M), and average EPS is $3.1 (high $3.14, low $3.06).
Did the SRCL's actual financial results beat the analysts' financial forecasts?
Based on Stericycle's last annual report (Dec 2023), the company's revenue was $2.66B, which missed the average analysts forecast of $2.69B by -1.17%. Apple's EBITDA was $77.3M, missing the average prediction of $361.38M by -78.61%. The company's net income was $-21.4M, missing the average estimation of $110.64M by -119.34%. Apple's SG&A was $873.9M, missing the average forecast of $991.33M by -11.85%. Lastly, the company's EPS was $-0.23, missing the average prediction of $1.85 by -112.46%. In terms of the last quarterly report (Dec 2023), Stericycle's revenue was $652M, missing the average analysts' forecast of $657.99M by -0.91%. The company's EBITDA was $37.1M, missing the average prediction of $87.46M by -57.58%. Stericycle's net income was $14.9M, missing the average estimation of $43.44M by -65.70%. The company's SG&A was $219.7M, beating the average forecast of $211.35M by 3.95%. Lastly, the company's EPS was $0.16, missing the average prediction of $0.467 by -65.75%